MS

Mark Saldanha

Active Director Managing Director DIN 00020983 India's Richest · #498
DIN 00020983 First appointment Nov 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 3 historical roles
Total affiliations 4 Since Nov 2007
Shareholding value •••• Premium profile

About Mark Saldanha

Data last updated:

Mark Saldanha is a Managing Director at Marksans Pharma Limited (since 2015). The companies operate in Pharma. Marksans Pharma Limited reported revenue of ₹3,033 Cr (FY 2026). Earlier, Mark Saldanha was a Director at Marise Laboratories Private Limited (from 2007) and Director at Merrill Laboratories Private Limtied (from 2007) and 1 more.

Mark Saldanha is #498 among India's richest people (2026), with wealth of ₹7,000 Cr.

DIN 00020983
Primary Designation Managing Director
Industry Pharma
First Appointment 02 Nov 2007
Oldest Company Age 34 yrs
Largest company Marksans Pharma Limited · ₹3,033 Cr (FY 2026)

Recognitions & Rankings

India's Richest People 2026 edition · Source: Hurun India
Rank#498
Wealth
₹7,000 Cr
Company
Marksans Pharma
2017 #571

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Marksans Pharma Limited L24110MH1992PLC066364
Managing Director06 Oct 20151992₹3,033 Cr (FY 2026)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Marise Laboratories Private Limited U24100MH2007PTC175669
Director02 Nov 20072007Strike Off
Merrill Laboratories Private Limtied U24232MH2007PTC176548
Director07 Dec 20072007Strike Off
Director03 Dec 20072007Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Mark Saldanha

NameDINCompanyDesignation
Abhinna Mohanty Sundar00007995Marksans Pharma LimitedDirector
Digant Mahesh Parikh00212589Marksans Pharma LimitedDirector
Harshavardhan PanigrahiMarksans Pharma LimitedCompany Secretary
Jitendra Mahabirprasad SharmaMarksans Pharma LimitedCfo
Sandra Saldanha00021023Marksans Pharma LimitedWhole-Time Director
Shailaja Vardhan10172764Marksans Pharma LimitedDirector
Srinivas Mishra10052055Marksans Pharma LimitedDirector
Sunny Sharma02267273Marksans Pharma LimitedDirector
Varddhman Vikramaditya Jain08338573Marksans Pharma LimitedWhole-Time Director

Directorship timeline

Open interactive timeline →
Marksans Pharma Limited
Marise Laboratories Private Limited
Merrill Laboratories Private Limtied
Schenelle Property Holdings Private Limited
Premium access

Shareholding and investment profile for Mark Saldanha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mark Saldanha

Mark Saldanha currently holds 1 directorship: Marksans Pharma Limited (Managing Director, since 06 Oct 2015, revenue ₹3,033 Cr (FY 2026)).

Mark Saldanha was first appointed on 02 Nov 2007 as Director at Marise Laboratories Private Limited. The most recent appointment on record is 06 Oct 2015 at Marksans Pharma Limited.

Mark Saldanha held 3 earlier board appointments: Marise Laboratories Private Limited (Director, from 02 Nov 2007); Merrill Laboratories Private Limtied (Director, from 07 Dec 2007); Schenelle Property Holdings Private Limited (Director, from 03 Dec 2007).

The current boards of Mark Saldanha's companies include Abhinna Mohanty Sundar (Marksans Pharma Limited), Digant Mahesh Parikh (Marksans Pharma Limited), Harshavardhan Panigrahi (Marksans Pharma Limited), Jitendra Mahabirprasad Sharma (Marksans Pharma Limited), Sandra Saldanha (Marksans Pharma Limited), Shailaja Vardhan (Marksans Pharma Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available